FDA Raises Concerns About Cell Therapeutics’ Cancer Drug

Drug reviewers working for the Food and Drug Administration raised concerns about the efficacy and safety of Cell Therapeutics’(CTIC Quote) lymphoma drug pixantrone drug, according to a review of the drug posted to the agency’s Web site Monday.

 
  Your Reaction?
  REACT WITH GIF
 

    Hot Buzz

    Guys Summer’s Cancelled, Sunnyboys Are Being Discontinued

    The Family Of Aboriginal Woman Who Died In Custody Wants Graphic Footage Released

    Now Buzzing